Key points
- The Advisory Committee on Immunization Practices (ACIP) develops recommendations on how to use vaccines to control disease in the United States.
- These recommendations become official ÐÇ¿ÕÓéÀÖ¹ÙÍø policy once adopted by ÐÇ¿ÕÓéÀÖ¹ÙÍø's Director.
- Learn about current and historical ACIP recommendations for hepatitis B vaccine.
Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the ÐÇ¿ÕÓéÀÖ¹ÙÍø regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the ÐÇ¿ÕÓéÀÖ¹ÙÍø Director and, if adopted, are published as official ÐÇ¿ÕÓéÀÖ¹ÙÍø/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Hepatitis B Vaccine Recommendations
For your convenience, these archived publications can be used for historical and research purposes.
MMWR, December 5, 2024, Vol 73(48);1106
Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19–59 Years — United States, 2024
Print version
MMWR, April 1, 2022, Vol 71(13);477–483
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Print version
MMWR, April 20, 2018, Vol 67(15);455-458
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
Print version
MMWR, January 12, 2018, Vol 67(RR-1);1-31
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
Print version
ARCHIVED Hepatitis B Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
MMWR, December 23, 2011, Vol 60(50);1709-1711
Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the ACIP
Print version
MMWR, October 12, 2007, Vol 56(40);1057
Notice to Readers: FDA Approval of an Alternate Dosing Schedule for a Combined Hepatitis A and B Vaccine (Twinrix®)
Print Version
MMWR, December 8, 2006, Vol 55(RR-16);1-25
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States—Part 2: Immunization of Adults
Print version (includes appendices)
MMWR, December 23, 2005, Vol 54(RR-16);1-23
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States—Part 1: Immunization of Infants, Children, and Adolescents
Print version (includes appendices)
MMWR, Mar 14, 2003, Vol 52(10);203-204
Notice to Readers: FDA Licensure of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Poliovirus Vaccine Combined, (PEDIARIX™) for Use in Infants
Print Version
MMWR, Sep 21, 2001, Vol 50(37);806-7
Notice to Readers: FDA Approval for a Combined Hepatitis A and B Vaccine
Print Version
MMWR, Mar 31, 2000, Vol 49(12);261
Notice to Readers: Alternate Two-Dose Hepatitis B Vaccination Schedule for Adolescents Aged 11-15 Years
Print Version